ECNP-PsychX talks
Bringing you the latest science in psychiatry
About PsychX and ECNP
Mental health expertise should be more accessible. This is the belief of Christiaan Vinkers, Jurjen Luykx, Frank Gerritse (psychiatrists and researchers) and Dido Prins (psychiatry resident). It resulted in launching PsychX, to give a platform to young as well as more experienced scientists working in mental health. PsychX has been providing you with monthly short online talks on a range of mental health topics. These talks are easy to access, with no registration or costs involved.
In 2022, PsychX and ECNP started collaborating. As from 2023, all PsychX talks will be transferred to ECNP. The concept of the talks stays the same: free, online talks with a Q&A where you can discuss your thoughts with the speaker directly.
These talks are free, online, monthly presentations with Q&A about a range of topics in clinical and more research-oriented psychiatry.
PsychX Programming Committee
The Committee meets twice a year (online) to select topics and suggest speakers for the programme of the following six months.
How to join the talks
Direct meeting link: https://us02web.zoom.us/j/85400808569?pwd=SU5MK21mV1lTVXZYVHpQeTRiVTNsQT09
Meeting ID: 854 0080 8569
Passcode: PSYCHX
One tap mobile
+31207940854,,85400808569#,,,,*885632# Netherlands
+31207946519,,85400808569#,,,,*885632# Netherlands
To prevent connection issues, please use the Zoom-app instead of the website.
Scheduled talks
These are the free online talks we have scheduled for 2023, every first Monday of the month at 16.30 -17.30 CET (Central European Time)/CEST (Central European Summer Time).
Monday 2 October 2023
Psycho-endocrinology — will there be a place for it in clinical practice?
Birit Broekman, The Netherlands
Birit Broekman is Professor in Hospital Psychiatry. Her clinical and research focus are related to the interconnection of psyche, soma and context. She finished a master in both Psychology (RUG) and Medicine (UvA), and after her training in Psychiatry (AMC), she worked for almost 10 years in Singapore (NUS), where she led her own research group. She completed her PhD (UvA) based on data from the Netherlands as well as Singapore in perinatal mental health, and as a Veni Laureate she developed further expertise in the relation between sex hormones, mood and sleep. She is currently involved in different research projects with the aim to improve integrated care for patients with mental and somatic health issues.
Monday 6 November 2023
Topic to be announced
Laura Berner, USA
Monday 4 December 2023
Clozapine, psychosis and OCD. Where to start?
Emilio Fernandez Egea, United Kingdom
Obsessive-compulsive symptoms (OCS) and disorder (OCD) are commonly seen in schizophrenia, especially in those treated with clozapine, a phenomenon yet to be understood. I will review the epidemiology and the pathophysiological hypothesis and elaborate a conceptual framework integrating the most recent findings to, finally, propose a treatment algorithm.
Emilio Fernandez Egea is a consultant psychiatrist at the Cambridgeshire and Peterborough NHS Foundation Trust and an affiliated associate professor at the University of Cambridge. His focus lies in schizophrenia and psychosis, leading the Cambridge Psychosis Centre. With over 120 original research papers, he is researching comorbidities' impact on schizophrenia and the concept of schizophrenia. His work extends beyond research, including deputy editorship at the British Journal of psychiatry and the Spanish Journal of psychiatry and mental health.
Monday 5 February 2024
Recent advances in bipolar disorder
Eduard Vieta, Spain
Bipolar disorders are one of the most difficult to diagnose and treat psychiatric conditions. Recent progress has focused on the genetics, neurobiology, and management of this condition. This talk will provide a crisp update of recent advances in the management of bipolar disorders.
Eduard Vieta is full professor of psychiatry at the University of Barcelona and head of the department of psychiatry and psychology at the Hospital Clinic. He has been neuroscience advisor for the European Union Presidency, invited professor at Harvard University, and honorary doctor by the University of Valencia. He is the most cited scientist worldwide in the field of bipolar disorder and has been named one of the “world’s most influential minds” by Clarivate Analytics. He has received many awards, including the World’s best researcher in biological psychiatry by the World Federation of Societies of Biological Psychiatry, the Colvin Prize, the Simon Bolivar Award, and the Trueta Award. This year he won the Distinction of the Faculty of Doctors and the Social Council of the University of Barcelona for excellent activities of scientific and humanistic dissemination.
Date to be announced
Topic to be announced
Rene Kahn
René Kahn is chair of psychiatry at the Icahn School of Medicine at Mount Sinai since 2017. After completing medical school in the Netherlands, he was trained as a psychiatrist and neurologist in Utrecht and Amsterdam. He subsequently completed his psychiatry residencies at Mount Sinai Hospital and then worked as chief of the psychiatry research unit at the Bronx VA. In 1993 he became chair of psychiatry at the University Hospital Utrecht, going on to lead the Brain Center Rudolf Magnus, which combines research in basic neuroscience, psychiatry and neurology. Kahn has published over 950 research papers with a web of science H index of 107. He has been continuously funded for over 25 years by NIMH, the EU, the Stanley Foundation, and other organisations. He has served on several neuroscience grant review boards. René Kahn received several honors, such as a Fulbright Scholarship, membership of the Royal Netherlands Academy of Arts and Sciences, the ECNP Neuropsychopharmacology Award, an honorary doctorate at Semmelweis University in Budapest, Hungary and the lifetime achievement award of the Netherlands Psychiatric Association. He was knighted in the Netherlands in 2018. He served as treasurer and vice-president of ECNP and as president of the Schizophrenia International Research Society. He is a fellow of the American College of Neuropsychopharmacology.
Previous talks
View here previous PsychX talks.
